Generate Biomedicines, Inc. (GENB)
Nasdaq: GENB · CIK 0002100782 · United States
Every official Generate Biomedicines, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open GENB filings
Generate Biomedicines, Inc. documents
- Generate Biomedicines, Inc. 10-K 2026GENB 10-K 2026: annual report for fiscal 2026
- Generate Biomedicines, Inc. 10-K 2025GENB 10-K 2025: annual report for fiscal 2025
- Generate Biomedicines, Inc. 10-K 2024GENB 10-K 2024: annual report for fiscal 2024
- Generate Biomedicines, Inc. 10-K 2023GENB 10-K 2023: annual report for fiscal 2023
- Generate Biomedicines, Inc. 10-K 2022GENB 10-K 2022: annual report for fiscal 2022
- Generate Biomedicines, Inc. 10-Q 2026GENB 10-Q 2026: quarterly report for fiscal 2026
- Generate Biomedicines, Inc. 10-Q 2025GENB 10-Q 2025: quarterly report for fiscal 2025
- Generate Biomedicines, Inc. 10-Q 2024GENB 10-Q 2024: quarterly report for fiscal 2024
- Generate Biomedicines, Inc. 10-Q 2023GENB 10-Q 2023: quarterly report for fiscal 2023
- Generate Biomedicines, Inc. 10-Q 2022GENB 10-Q 2022: quarterly report for fiscal 2022
- Generate Biomedicines, Inc. 8-K 2026GENB 8-K 2026: current report for fiscal 2026
- Generate Biomedicines, Inc. 8-K 2025GENB 8-K 2025: current report for fiscal 2025
- Generate Biomedicines, Inc. 8-K 2024GENB 8-K 2024: current report for fiscal 2024
- Generate Biomedicines, Inc. 8-K 2023GENB 8-K 2023: current report for fiscal 2023
- Generate Biomedicines, Inc. 8-K 2022GENB 8-K 2022: current report for fiscal 2022
- Generate Biomedicines, Inc. DEF 14A 2026GENB DEF 14A 2026: proxy statement for fiscal 2026
- Generate Biomedicines, Inc. DEF 14A 2025GENB DEF 14A 2025: proxy statement for fiscal 2025
- Generate Biomedicines, Inc. DEF 14A 2024GENB DEF 14A 2024: proxy statement for fiscal 2024
- Generate Biomedicines, Inc. DEF 14A 2023GENB DEF 14A 2023: proxy statement for fiscal 2023
- Generate Biomedicines, Inc. DEF 14A 2022GENB DEF 14A 2022: proxy statement for fiscal 2022
- Generate Biomedicines, Inc. Form 4 2026GENB Form 4 2026: insider trading filing for fiscal 2026
- Generate Biomedicines, Inc. Form 4 2025GENB Form 4 2025: insider trading filing for fiscal 2025
- Generate Biomedicines, Inc. Form 4 2024GENB Form 4 2024: insider trading filing for fiscal 2024
- Generate Biomedicines, Inc. Form 4 2023GENB Form 4 2023: insider trading filing for fiscal 2023
- Generate Biomedicines, Inc. Form 4 2022GENB Form 4 2022: insider trading filing for fiscal 2022
- Generate Biomedicines, Inc. S-1 2026GENB S-1 2026: registration statement for fiscal 2026
- Generate Biomedicines, Inc. S-1 2025GENB S-1 2025: registration statement for fiscal 2025
- Generate Biomedicines, Inc. S-1 2024GENB S-1 2024: registration statement for fiscal 2024
- Generate Biomedicines, Inc. S-1 2023GENB S-1 2023: registration statement for fiscal 2023
- Generate Biomedicines, Inc. S-1 2022GENB S-1 2022: registration statement for fiscal 2022
- Generate Biomedicines, Inc. 13F 2026GENB 13F 2026: institutional holdings for fiscal 2026
- Generate Biomedicines, Inc. 13F 2025GENB 13F 2025: institutional holdings for fiscal 2025
- Generate Biomedicines, Inc. 13F 2024GENB 13F 2024: institutional holdings for fiscal 2024
- Generate Biomedicines, Inc. 13F 2023GENB 13F 2023: institutional holdings for fiscal 2023
- Generate Biomedicines, Inc. 13F 2022GENB 13F 2022: institutional holdings for fiscal 2022
More companies